Quality & Compliance For Continuous Improvement

Essential Learning Resources from NSF International, Pharma Biotech

Have A Question? Get In Touch

Check out some of our latest learning resources and get your company into the quality mindset with our short video.

Being in compliance doesn't equal good quality. In this NSF video, expert Maxine Fritz, Executive Vice President, Pharma Biotech, provides an overview of our team and capabilities, including how we follow a holistic quality approach to help you build the right quality mindset, anywhere across the globe. Watch the video >>

For more information on our services including auditing, consultancy, quality systems, regulatory guidance and training, contact pharmamail@nsf.org or visit www.nsfpharmabiotech.org

Webinar: Using Behavioral GMP to Create Perpetual GMP Inspection Readiness

White Paper: How to Write to Regulatory Agencies When Things Go Wrong

White Paper: The Future of the Pharmaceutical Industry

Video: Is Your Pharmaceutical Facility Aging?

Using Behavioral GMP to Create Perpetual GMP Inspection Readiness

How do the best companies remain inspection ready by design rather than good fortune? In this webinar, John Johnson covers what perpetual GMP compliance means and details how you and your organization can achieve it. He also introduces the basic toolkit used for inspection preparation.

How to Write to Regulatory Agencies When Things Go Wrong

Responding to severe regulatory criticism? Need some essential guidance? This white paper includes step-by-step guidance on how to write to regulatory agencies when things go wrong.

The Future of the Pharmaceutical Industry

In this white paper, Martin Lush explains his view of the future of the pharmaceutical industry, and provides some key facts and essential back-to-basics advice on how you can prosper in an uncertain, ever-changing world.

Aging Facilities

Aging facilities is a relatively new issue impacting the pharma biotech industry. Just because your facility is chronologically older, doesn’t necessarily mean it is aging! In this short video, expert Nicholas Markel explains the issue, how to find out if you have an aging facility (by addressing five key questions) and how to prevent aging facilities.

A Beginner’s Guide To Quality Risk Management (QRM)  

The pharmaceutical industry approach to assessing and controlling quality risks has largely been empirical. This is often fine but in more complex or hazardous situations, the pharmaceutical industry could benefit from a number of very helpful tools and techniques. 

> > Discover more

SIGN UP FOR YOUR COMPLIMENTARY PHARMA JOURNAL AND MONTHLY E-JOURNAL – VISIT OUR WEBSITE 

Stay in touch - follow us on 

Go to article: Home | Getting PersonalGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: In this issueGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: ContentsGo to article: Novo NordiskGo to article: NewsGo to article: PhoenixGo to article: The Pharma Industry BriefingGo to article: Nelson Lab Company InsightGo to article: Nelson LabsGo to article: Manufacturing personalised meds: what needs to change?Go to article: Molnar Company InsightGo to article: MolnarGo to article: Selling cells: the economics of CAR-T therapyGo to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Using AI to personalise drug combination therapyGo to article: NSFGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Nipro PharmaPackagingGo to article: A summer of manufacturing disasters for Chinese pharmaGo to article: CapsugelGo to article: EndocaGo to article: ContraFect’s Staph infection drug may succeed in trial but caveats remainGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: Why are novel therapies for glioblastoma patients not gaining approvals?Go to article: Lubrizol Life SciencesGo to article: QualiMetriXGo to article: CAR-T approved in Europe but NICE verdict is divided: what happens next?Go to article: Palleos healthcare GmbH Go to article: Daiichi JitsugyoGo to article: EventsGo to article: Nemera Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Next issueGo to article: NemeraGo to article: Plastiape Go to article: General Electric Healthcare